| __timestamp | Intra-Cellular Therapies, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 176081000 |
| Thursday, January 1, 2015 | 139626 | 157939000 |
| Friday, January 1, 2016 | 93831530 | 164073000 |
| Sunday, January 1, 2017 | 79419009 | 169243000 |
| Monday, January 1, 2018 | 368673 | 168489000 |
| Tuesday, January 1, 2019 | 477121 | 172526000 |
| Wednesday, January 1, 2020 | 1895029 | 200649000 |
| Friday, January 1, 2021 | 8034589 | 237513000 |
| Saturday, January 1, 2022 | 20443000 | 353358000 |
| Sunday, January 1, 2023 | 33745000 | 586886000 |
Unleashing insights
In the ever-evolving landscape of healthcare, understanding the financial dynamics of key players is crucial. This analysis delves into the cost of revenue trends for Intra-Cellular Therapies, Inc. and Lantheus Holdings, Inc. from 2014 to 2023.
Intra-Cellular Therapies, Inc., a biopharmaceutical company, has seen a significant increase in its cost of revenue, growing from a modest $140,000 in 2015 to over $33 million in 2023. This represents a staggering increase of over 23,000%, reflecting the company's expansion and increased operational activities.
Lantheus Holdings, Inc., specializing in diagnostic imaging, has also experienced a notable rise in its cost of revenue. From $158 million in 2015, it surged to nearly $587 million in 2023, marking a 270% increase. This growth underscores the company's scaling operations and market penetration.
Cost of Revenue Comparison: Sanofi vs Intra-Cellular Therapies, Inc.
Cost Insights: Breaking Down Biogen Inc. and Lantheus Holdings, Inc.'s Expenses
Cost of Revenue Comparison: BeiGene, Ltd. vs Lantheus Holdings, Inc.
Cost Insights: Breaking Down Intra-Cellular Therapies, Inc. and Insmed Incorporated's Expenses
Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs HUTCHMED (China) Limited
Intra-Cellular Therapies, Inc. vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and Lantheus Holdings, Inc.
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs CRISPR Therapeutics AG
Cost of Revenue Trends: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Bausch Health Companies Inc.'s Expenses